Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases

International Journal of Cancer

Volumn 82, Issue 4, 1999, Pages 477-483

  Dueck, Margret ^a   Riedl, Stefan ^a   Hinz, Ulf ^a   Tandara, Andrea ^a   Möller, Peter ^a   Herfarth, Christian ^a   Faissner, Andreas ^b,c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CENTRE DE NEUROCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 19H12; MONOCLONAL ANTIBODY J1TN1; TENASCIN; TISSUE EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER STAGING; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; DENSITOMETRY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; TISSUE DISTRIBUTION; ULCERATIVE COLITIS;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; TENASCIN; UP-REGULATION;

EID: 0032864433     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<477::AID-IJC2>3.0.CO;2-5     Document Type: Article

References (20)

1. FAISSNER, A. and KRUSE, J., J 1/tenascin is a repulsive substrate for central nervous system neurons. Neuron, 5, 627-637 (1990).
2. GÖTZ, B., SCHOLZE, A., CLEMENT, A., JOESTER, A., SCHÜTTE, K., WIGGER, F., FRANK, R., SPIESS, E., EKBLOM, P. and FAISSNER, A., Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J. Cell Biol., 132, 681-699 (1996).
3. HARADA, T., SHINOHARA, M., NAKAMURA, S. and OKA, M., An immunhistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch., 424, 257-266 (1994).
4. HAUPTMANN, S., ZARDI, L., SIRI, A., CARNEMOLLA, B., BORSI, L., CASTELLUCCI, M., KLOSTERHALFEN, B., HARTUNG, P., WEIS, J., STÖCKER, G., HAUBECK, H.-D. and KIRKPATRICK, C.J., Extracellular matrix proteins in colorectal carcinomas. Lab. Invest., 73, 172-182 (1995).
5. HUSMANN, K., FAISSNER, A. and SCHACHNER, M., Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J. Cell Biol., 116, 1475-1486 (1992).
6. ISKAROS, B.F., TANAKA, K.E., HU, X., KADISH, A.S. and STEINBERG, J.J., Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer. J. surg. Oncol., 64, 98-101 (1997).
7. LOCHTER, A., VAUGHAN, L., KAPLONY, A., PROCHIANTZ, A., SCHACHNER, M. and FAISSNER, A., J 1/tenascin in substrate bound and soluble form displays contrary effects on neurite outgrowth. J. Cell Biol., 113, 1159-1171 (1991).
8. MACKIE, E.J., CHIQUET-EHRISMANN, R., PEARSON, C.A., INAGUMA, Y., TAYA, K., KAWARADA, Y. and SAKAKURA, T., Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. nat. Acad. Sci. (Wash.), 84, 4621-4625 (1987).
9. MIGHELL, A.J., THOMPSON, J., HUME, H.J., MARKHAM, A.F. and ROBINSON, P.A., Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int. J. Cancer, 72, 236-240 (1997).
10. MOCH, H., TORHORST, J., DÜRMÜLLER, U., FEICHTER, G.E., SAUTER, G. and GUDAT, F., Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Pathol. Res. Pract., 189, 510-514 (1993).
11. NAKAO, N., HIRAIWA, N., YOSHIKI, A., IKE, F. and KUSAKABE, M., Tenascin-C promotes healing of habu-snake venom - induced glomerulonephritis. Am. J. Pathol., 152, 1237-1245 (1998).
12. RACHMILEWITZ, D., Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Brit. med. J., 298, 82-86 (1989).
13. RIEDL, S., BODENMÜLLER, H., HINZ, U., HOLLE, R., MÖLLER, P., SCHLAG, P., HERFARTH, C. and FAISSNER, A., Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int. J. Cancer, 64, 65-69 (1995).
14. RIEDL, S., KADMON, M., TANDARA, A., HINZ, U., MÖLLER, P., HERFARTH, C. and FAISSNER, A., Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel. Dis. Colon Rectum, 41, 86-92 (1998).
15. RIEDL, S.E., FAISSNER, A., SCHLAG. P., VON HERBAY, A., KORETZ, K. and MÖLLER, P., Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology, 103, 400-406 (1992).
16. SAKAI, T., KAWAKATSU, H., HIROTA, N., YOKOYAMA, T., SAKAKURA, T. and SAITO, M., Specific expression of tenascin in human colonic neoplasms. Brit. J. Cancer, 67, 1058-1064 (1993).
17. SCHEFFLER, B., FAISSNER, A., BECK, H., BEHLE, K., WOLF, H.K., WIESTLER, O.D. and BLÜMCKE, I., Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis. Glia, 19, 35-46 (1997).
18. SCHENK, S., MUSER, J., VOLLMER, G. and CHIQUET-EHRISMANN, R., Tenascin-C in serum: a questionable tumor marker. Int. J. Cancer, 61, 443-449 (1995).
19. SHOJI, T., KAMIYA, T., TSUBURA, A., YOSHINORI, H., HATANO, T., HIOKI, K. and MORII, S., Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J. surg. Res., 55, 295-297 (1993).
20. SUGAWARA, I., HIRAKOSHI, J., KUSAKABE, M., MASUNAGA, A., ITOYAMA, S. and SAKAKURA, T., Relationships among tenascin expression, DNA ploidy, patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma. Jpn. J. Cancer Res., 84, 703-707 (1993).